Posted on 3/2/21
University of Maryland St. Joseph Medical Center Named Among America’s 100 Best Hospitals by Healthgrades
Baltimore Community Hospital Achieves Distinction for Second Consecutive Year For the second year in a row, Healthgrades, a leading online resource for comprehensive information about physicians . . .
Posted on 3/2/21
Baltimore Convention Center Field Hospital Launches Pilot Program To Vaccinate Most Vulnerable Populations
New program focuses on equitable COVID-19 vaccine allocation for at-risk communitiesThe Baltimore Convention Center Field Hospital (BCCFH), a public-private partnership of the Maryland Department of Health, . . .
Posted on 3/1/21
MBF Bioscience Acquires Vidrio Technologies
MBF Bioscience, a leading provider of bioscience image analysis tools, announced today that it has completed
Posted on 3/1/21
Greater Washington Oncology Associates Joins the American Oncology Network
Fort Myers, Fla., March 01, 2021 (GLOBE NEWSWIRE) -- American Oncology Network, LLC (AON), a high-growth national network of independent community oncologists, is pleased to announce . . .
Posted on 3/1/21
Virginia Could Get 400K+ COVID Vaccine Doses for First Week of March
Virginia could receive up to 433,000 doses of COVID-19 vaccine doses for the first week of March, depending on the timing of the U.S. Food and . . .
Posted on 3/1/21
Johnson & Johnson vs. Novavax: Which Vaccine Is Best Against New Strains?
Moderna (NASDAQ:MRNA) and Pfizer (NYSE:PFE) may soon be sharing the coronavirus vaccine market with two more companies. Johnson & Johnson and Novavax are approaching the finish . . .
Posted on 2/28/21
Number of Marylanders Hospitalized with COVID-19 Continue to Decline
Maryland’s coronavirus-related hospitalizations have decreased for four consecutive days and the metric has been trending downward for about six weeks.OF the 943 Marylanders currently hospitalized with . . .
Posted on 2/28/21
Supernus Pharmaceuticals: Solid Quarter, Solid Stock
Today, we revisit biopharma concern Supernus Pharmaceuticals whose just reported 4th quarter results that triggered a near 10% selloff in its stock.However, the company reported solid . . .
Posted on 2/26/21
Immunic Reports Year End 2020 Financial Results
Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, today announced . . .
Posted on 2/26/21
Byrna Technologies Reports Record Fourth Quarter And Full Fiscal 2020 Results
Byrna Technologies Inc. (OTCQB: BYRN) (CSE: BYRN) today announced results for its fiscal fourth quarter ended November 30, 2020.Fourth Quarter 2020 Compared to Fourth Quarter 2019: . . .
Posted on 2/26/21
Thermo Fisher Scientific Acquires Mesa Biotech
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced it has completed its previously announced acquisition of Mesa Biotech, Inc., a . . .
Posted on 2/26/21
Amneal Reports Fourth Quarter and Full Year 2020 Financial Results
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (NYSE: AMRX) announced its results today for the fourth quarter and full year ended December 31, 2020."We are extremely proud of the . . .
Posted on 2/26/21
Icahn Enterprises Reports Fourth Quarter and Full Year 2020 Financial Results
SUNNY ISLES BEACH, Fla., Feb. 26, 2021 (GLOBE NEWSWIRE) -- Icahn Enterprises L.P. (Nasdaq:IEP) is reporting fourth quarter 2020 revenues of $2.8 billion and net income . . .
Posted on 2/26/21
Relivant to Acquire Silicon Therapeutics for $450 Million
Roivant Sciences today announced it has entered into a definitive agreement to acquire Silicon Therapeutics for $450 million in Roivant equity, with additional potential regulatory and . . .
Posted on 2/26/21
Mersana Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
CAMBRIDGE, Mass., Feb. 26, 2021 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates . . .
Posted on 2/26/21
Hogan Looks Forward To New Vaccine During Stadium Site Visit
Emergency use authorization of Johnson & Johnson’s vaccine would provide a huge boost to Maryland’s efforts to fill the gulf of supply in the state’s vaccine . . .
Posted on 2/25/21
Broward Health: COVID Impacts Heart Health
COVID-19 is wreaking havoc in all areas of our lives, but for those who have been infected, there is the added impact the disease may have . . .
Posted on 2/25/21
PediaMetrix Receives $1M from the National Science Foundation
PediaMetrix has been awarded a National Science Foundation (NSF) Small Business Innovation Research
Posted on 2/25/21
Insmed Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today reported financial results for . . .
Posted on 2/25/21
Provention Bio Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today reported financial results for the fourth quarter and full year . . .
Posted on 2/25/21
Biocytogen Acquires Antibody Discovery Platform
Biocytogen, a company dedicated to accelerating therapeutic antibody discovery, has announced the acquisition of a third Beacon Optofluidic system.
Posted on 2/25/21
Akebia Reports Fourth Quarter and Full-Year 2020 Financial Results and Provides Business Updates
Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose of bettering the lives of people impacted by kidney disease, today reported financial results for . . .
Posted on 2/25/21
Medisafe Secures $30M in Series C
Medisafe, a leading digital therapeutics company creating digital drug companions, today announced that it has raised $30 million in Series C funding with investments led by . . .
Posted on 2/25/21
Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial and Operational Results
CRANBURY, N.J.--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders, today reports financial . . .
Posted on 2/25/21
Moderna Reports Fourth Quarter and Fiscal Year 2020 Financial Results and Provides Business Updates
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today reported financial results and provided business updates for the . . .
